Literature DB >> 28949279

Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005-2014.

Li-Fen Hu1,2, Xi-Hai Xu1, Hong-Ru Li3, Li-Ping Gao1, Xi Chen1, Nian Sun1, Yan-Yan Liu1,2, Hua-Fa Ying1, Jia-Bin Li1,2,4.   

Abstract

The antimicrobial resistance pattern was studied among 300 Stenotrophomonas maltophilia isolates collected from 300 nonduplicated inpatients. The average age of the patients was 73.5 ± 14.6 years old. Isolates nonsusceptible to levofloxacin, chloramphenicol, minocycline or trimethoprim/sulfamethoxazole (SXT) were more prevalent in the 99 patients aged over 81 years than in the other patients (p < 0.05). Multidrug resistance was found to be significantly associated with isolates recovered from the blood (72.7%, p = 0.000) and elderly patients (31.3%, p = 0.003). A trend of increased resistance to antimicrobials and higher and higher frequencies of multidrug-resistant isolates were observed through the 10-year period, wherein the percentage of isolates resistant to SXT was significantly changed from 29.7% in 2005-2009 to 47.1% in 2010-2014 (p = 0.02). Clinicians are recommended to pay special attention to the possibility of multidrug-resistant S. maltophilia infection in elderly inpatients.

Entities:  

Keywords:  Stenotrophomonas maltophilia; antimicrobial agents; resistance; trimethoprim/sulfamethoxazole

Mesh:

Substances:

Year:  2017        PMID: 28949279     DOI: 10.1080/1120009X.2017.1378834

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  10 in total

Review 1.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

2.  Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.

Authors:  Maria F Mojica; Joseph D Rutter; Magdalena Taracila; Luciano A Abriata; Derrick E Fouts; Krisztina M Papp-Wallace; Thomas J Walsh; John J LiPuma; Alejandro J Vila; Robert A Bonomo
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

3.  Effects of Tigecycline Combined with Azithromycin Against Biofilms of Multidrug-Resistant Stenotrophomonas maltophilia Isolates from a Patient in China.

Authors:  ChengCheng Yue; WeiHua Shen; LiFen Hu; YanYan Liu; YaHong Zheng; Ying Ye; Yuhao Zhang; JiaBin Li
Journal:  Infect Drug Resist       Date:  2021-02-26       Impact factor: 4.003

4.  Risk Factors for Mortality in Hospitalized Patients with Stenotrophomonas maltophilia Bacteremia.

Authors:  Jiyong Jian; Zeqiang Xie; Liang Chen
Journal:  Infect Drug Resist       Date:  2022-07-21       Impact factor: 4.177

5.  Community-Acquired Stenotrophomonas Maltophilia Infection in a Child: A Case Report and Literature Review.

Authors:  ZhiHong Jiang; YiFan Ren; ChuanXin Zhang; Yu Yin; ChaoHui Li
Journal:  Infect Drug Resist       Date:  2022-09-19       Impact factor: 4.177

6.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

7.  Molecular and Conventional Analysis of Acute Diarrheal Isolates Identifies Epidemiological Trends, Antibiotic Resistance and Virulence Profiles of Common Enteropathogens in Shanghai.

Authors:  Feng Yang; Yonggen Jiang; Lihua Yang; Juanxiu Qin; Mingquan Guo; Yuxia Lu; Hongyou Chen; Yuan Zhuang; Jinghao Zhang; Hong Zhang; Zhaoyun Dai; Min Li; Changqing Yang; Min Chen; Yanmei Zhang; Hu Zhao
Journal:  Front Microbiol       Date:  2018-02-09       Impact factor: 5.640

8.  Clinical and Molecular Epidemiology of Stenotrophomonas maltophilia in Pediatric Patients From a Chinese Teaching Hospital.

Authors:  Zhongliang Duan; Juanxiu Qin; Cui Li; Chunmei Ying
Journal:  Front Cell Infect Microbiol       Date:  2020-08-11       Impact factor: 5.293

9.  Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.

Authors:  Zhongliang Duan; Juanxiu Qin; Yao Liu; Cui Li; Chunmei Ying
Journal:  BMC Microbiol       Date:  2020-09-29       Impact factor: 3.605

10.  Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study.

Authors:  Lei Zha; Dayan Zhang; Lingling Pan; Zhichu Ren; Xiang Li; Yi Zou; Shirong Li; Shuangqi Luo; Gang Yang; Boris Tefsen
Journal:  Infect Dis Ther       Date:  2021-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.